BIOSPECIFICS TECHNOLOGIES CORP: key financial figures for fiscal year 2019 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2019)

$38.2M

Net Income/Loss (FY2019)

$24.5M

Total Assets (FY2019)

$126.7M

Total Equity (FY2019)

$124.5M

Cash Flows from Operating Activities (FY2019)

$22.3M

Source: BIOSPECIFICS TECHNOLOGIES CORP 10-K filing (FY2019). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.